Chardan Capital downgrades CARGO Therapeutics, Inc. (CRGX) to a Hold
CARGO Therapeutics, Inc. (CRGX – Research Report) received a Hold rating and price target from Chardan Capital analyst Geulah Livshits ...
Cell Therapy Regenerative Medicine Market Expected To Flourish At 15.78% CAGR To 170.0 Billion USD Gilead Sciences
The Cell Therapy Regenerative Medicine market is poised for significant growth, driven by advancements in technology and increasing acceptanc ...
bovnews5d
Editas Medicine Inc (EDIT) Stock Trading Recap
JP Morgan has recently reduced Editas Medicine Inc (EDIT) stock to Underweight rating, as announced on December 16, 2024, according to Finviz. Earlier, on December 13, 2024, Truist had reduced the ...